News

Business

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold

Edward Kim | Equities.com |

"Temporarily on hold," Musk tweeted Friday morning.


Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users

Edward Kim | Equities.com |

The women-first dating service had 24% revenue growth in Q1.


Squarespace Beats Revenue Estimates With Record Q1

Equities Staff | Equities.com |

The company posted $208 million in revenue for the first quarter.


BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million

Edward Kim | Equities.com |

BMY will pay BBIO $90 million in upfront cash.


AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Equities Staff | Equities.com |

The companies are facing over 3,500 opioid-related lawsuits.


Cigna Beats Q1 Revenue and Earnings Estimates, Raises Full Year Guidance

Edward Kim | Equities.com |

Growth was driven by its Evernorth health services unit.


PepGen Goes Public in $108 Million IPO

Edward Kim | Equities.com |

The company is developing treatments for serious genetic diseases, with an initial focus on neuromuscular diseases.


Bausch + Lomb Raises $630 Million in IPO, Missing Expectations

Edward Kim | Equities.com |

The stock was priced at $18 per share, off a filing range of $21 - $24.


Aeglea BioTherapeutics Raises $45 Million Via Registered Direct Offering

Edward Kim | Equities.com |

The company is waiting on FDA review of its lead product candidate.


Biogen CEO Michel Vounatsos To Step Down After Commercial Failure of Alzheimer's Drug

Edward Kim | Equities.com |

Biogen will also halt marketing of Aduhelm.


Sponsored Financial Content

Market Movers